Vol 76, No 6 (2018)

Date published: 2018-06-11

Table of Contents

open access

paid access

EDITORIALS

Does prior percutaneous coronary intervention influence the outcome of coronary artery bypass grafting? One size does not fit all

Giampaolo Niccoli, Rocco A. Montone

DOI: 10.5603/KP.2018.0115
Pubmed: 29905362
Kardiol Pol 2018;76(6):933-934.

Familial hypercholesterolaemia: a look toward the East

Jean Ferrières

DOI: 10.5603/KP.2018.0116
Pubmed: 29905363
Kardiol Pol 2018;76(6):935-936.
Reviews

Dual and triple antithrombotic therapies: current patterns of practice and controversies

Mark A. Crowther, John W. Eikelboom

DOI: 10.5603/KP.a2018.0112
Pubmed: 29781069
Kardiol Pol 2018;76(6):937-944.

Antiplatelet therapy for patients undergoing coronary artery bypass surgery

Christine M. DeStephan, David J. Schneider

DOI: 10.5603/KP.a2018.0111
Pubmed: 29781070
Kardiol Pol 2018;76(6):945-952.
Original articles

Impact of previous percutaneous coronary interventions on the course and clinical outcomes of coronary artery bypass grafting

Paweł Bugajski, Krzysztof Greberski, Michał Kuzemczak, Ryszard Kalawski, Radosław Jarząbek, Tomasz Siminiak

DOI: 10.5603/KP.a2018.0039
Pubmed: 29399760
Kardiol Pol 2018;76(6):953-959.

Prevalence, diagnosis, and treatment of familial hypercholesterolaemia in outpatient practices in Poland

Krzysztof Chlebus, Barbara Cybulska, Marcin Gruchała, Anna Smaga, Katarzyna Wróbel, Bogdan Wojtyniak, Marcin Pajkowski, Piotr Jankowski, Tomasz Zdrojewski

DOI: 10.5603/KP.a2018.0053
Pubmed: 29399758
Kardiol Pol 2018;76(6):960-967.

Postoperative kinetics of common inflammatory biomarkers after congenital heart defect procedures with extracorporeal circulation in children

Ireneusz Haponiuk, Radosław Jaworski, Konrad Paczkowski, Maciej Chojnicki, Mariusz Steffens, Aneta Szofer-Sendrowska, Katarzyna Gierat-Haponiuk, Ewelina Kwaśniak, Marta Paśko-Majewska, Katarzyna Leszczyńska, Jacek Zieliński, Wiktor Szymanowicz

DOI: 10.5603/KP.a2018.0038
Pubmed: 29399761
Kardiol Pol 2018;76(6):968-973.

The effects of supraphysiological oestrogen levels on ventricular repolarisation parameters

Omer Yiginer, Mehmet Dogan, Ismet Gun, Huseyin Tayfun Kutlu, Gokhan Degirmencioglu, İlkin Guliyev, Alptug Tokatli, Fethi Kilicaslan

DOI: 10.5603/KP.a2018.0037
Pubmed: 29399762
Kardiol Pol 2018;76(6):974-979.

Which position should we take during newborn resuscitation? A prospective, randomised, multicentre simulation trial

Jacek Smereka, Halla Kaminska, Wojciech Wieczorek, Marek Dąbrowski, Jerzy Robert Ładny, Kurt Ruetzler, Łukasz Szarpak, Oliver Robak, Michael Frass

DOI: 10.5603/KP.a2018.0030
Pubmed: 29350383
Kardiol Pol 2018;76(6):980-986.

MiR-130a inhibition protects rat cardiac myocytes from hypoxia-triggered apoptosis by targeting Smad4

Yuanshi Li, Yingrong Du, Junxian Cao, Qianping Gao, Hongjuan Li, Yangjun Chen, Nihong Lu

DOI: 10.5603/KP.a2018.0040
Pubmed: 29399759
Kardiol Pol 2018;76(6):993-1001.

Significant mitral regurgitation as a predictor of long-term prognosis in patients receiving cardiac resynchronisation therapy

Han Jin, Shengwen Yang, Wei Hua, Min Gu, Hongxia Niu, Ligang Ding, Jing Wang, Cong Xue, Shu Zhang

DOI: 10.5603/KP.a2018.0035
Pubmed: 29399763
Kardiol Pol 2018;76(6):987-992.

Clinical usefulness of epicardial adipose tissue in patients with high-intermediate pre-test probability for coronary artery disease

Regayip Zehir, Ahmet Güner, Mert Ilker Hayiroglu, Tugba Kemaloğlu Oz, Altug Osken, Huseyin Aksu, Sennur Unal Dayi, Gultekin Faik Hobikoğlu

DOI: 10.5603/KP.a2018.0054
Pubmed: 29399757
Kardiol Pol 2018;76(6):1002-1008.
Short communications

miR-1, miR-21, and galectin-3 in hypertensive patients with symptomatic heart failure and left ventricular hypertrophy

Mariusz Tomaniak, Grażyna Sygitowicz, Olga Błaszczyk, Łukasz Kołtowski, Dominika Puchta, Karolina Malesa, Janusz Kochanowski, Dariusz Sitkiewicz, Krzysztof J. Filipiak

DOI: 10.5603/KP.2018.0117
Pubmed: 29905364
Kardiol Pol 2018;76(6):1009-1011.

Dysregulations of miRNAs and galectin-3 may underlie left ventricular dilatation in patients with systolic heart failure

Mariusz Tomaniak, Grażyna Sygitowicz, Krzysztof J. Filipiak, Olga Błaszczyk, Łukasz Kołtowski, Aleksandra Gąsecka, Janusz Kochanowski, Dariusz Sitkiewicz

DOI: 10.5603/KP.2018.0118
Pubmed: 29905365
Kardiol Pol 2018;76(6):1012-1014.

Cardiac retransplantation as a promising treatment option for late graft failure — Zabrze experience

Grzegorz M. Kubiak, Radosław Kwieciński, Michał Zakliczyński, Michał Hawranek, Jerzy Nożyński, Bogumiła Król, Piotr Przybyłowski, Alexander Suchodolski, Michał O. Zembala

DOI: 10.5603/KP.2018.0119
Pubmed: 29905366
Kardiol Pol 2018;76(6):1015-1017.

Percutaneous stellate ganglion block as an adjunctive therapy in the treatment of incessant ventricular tachycardia

Andrzej Przybylski, Janusz Romanek, Marcin Chlebuś, Bernadetta Deręgowska, Jerzy Kuźniar

DOI: 10.5603/KP.2018.0120
Pubmed: 29905367
Kardiol Pol 2018;76(6):1018-1020.
Clinical vignettes

Crossing of coronary arteries

Anna M. Michałowska, Paweł Tyczyński, Mariusz Kruk, Adam Witkowski, Ilona Michałowska

DOI: 10.5603/KP.2018.0121
Pubmed: 29905368
Kardiol Pol 2018;76(6):1021.

Intraoperative view on a rare but life-threatening complication of myocardial infarction

Jacek Piątek, Anna Kędziora, Janusz Konstanty-Kalandyk, Krzysztof Wróbel, Bogusław Kapelak

DOI: 10.5603/KP.2018.0122
Pubmed: 29905369
Kardiol Pol 2018;76(6):1022.

Giant small-cell neuroendocrine carcinoma infiltrating the heart

Anna E. Płatek, Robert Kowalik, Filip M. Szymanski, Krzysztof J. Filipiak

DOI: 10.5603/KP.2018.0123
Pubmed: 29905370
Kardiol Pol 2018;76(6):1023.

A rare cause of ventricular fibrillation after atrioventricular node ablation: what is the mechanism?

Predrag Stojadinović, Petr Peichl, Dan Wichterle, Josef Kautzner

DOI: 10.5603/KP.2018.0124
Pubmed: 29905371
Kardiol Pol 2018;76(6):1024.

Atrioventricular conduction limited to accessory pathway

Marek Kiliszek, Elżbieta Kramarz

DOI: 10.5603/KP.2018.0125
Pubmed: 29905372
Kardiol Pol 2018;76(6):1025.

Leadless pacemaker and subcutaneous implantable cardioverter-defibrillator therapy: the first use of a novel treatment option in Poland

Krzysztof Kaczmarek, Bartosz Czarniak, Piotr Jakubowski, Jerzy K. Wranicz, Paweł Ptaszyński

DOI: 10.5603/KP.2018.0126
Pubmed: 29905373
Kardiol Pol 2018;76(6):1026.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl